TNFRSF9 and B-cell non-Hodgkin lymphoma: Kobayashi et al. have reported on an α-GalCer-loaded B cell lymphoma (Eμ-myc tumor) combined with an agonistic antibody targeting 4-1BB (CD137) (55).